July 3, 2024
Industry Leaders React to FDA’s Newly Announced Diversity Action Plan Guidance
Pamela Tenaerts, MD, MBA, chief scientific officer, Medable; Luke Gelinas, PhD, senior chair director, Advarra; and Pam Diamond, MD, chief medical officer & co-founder, Curavit share their initial thoughts on the announcement of FDA’s Diversity Action Plan guidance.
By taking a research-based approach, clinical trials can become more diverse and better serve the needs of all individuals.
Enhance Early Protocol Design with Evidence-Driven Insights
Scarcity of data and siloed data sources lead to gaps in information that create challenges in study design. Additionally, the increase in trial complexity, which has seen a 600% increase in collected data points, contributes to a negative impact on a variety of trial performance outcomes. Evidence-based insights help study teams iterate upon ideas that can lead to lean study designs, resulting in reduced data points, decreased costs, and less deviations.
This webinar uncovers how technology and analytics can be applied to address key areas during study design/synopsis development. Learn how design analytics can help sponsors make early, in-flight design decisions prior to protocol authoring, such as selecting best endpoints, determining which eligibility criteria will improve probability of success, and identifying key regulatory design considerations.
Alzheimer’s Disease Treatments: What to Know About New and Future Drugs
Newly approved Kisunla promises to slow the disease, but patients will have to consider risks and reimbursement.
Walgreens Strengthens Support for Children and Adults Living with Diabetes
The retail pharmacy chain will highlight a variety of offerings and healthcare solutions for managing diabetes at Friends for Life Conference hosted by Children with Diabetes.
Pharmaceutical Commerce Magazine on LinkedIn
Understanding the Impact of the Veradigm® Network on Value-Based Healthcare Delivery
Learn more in this article about how Veradigm®’s comprehensive network and data capabilities support biopharma in achieving patient-centered, cost-effective care.
Read the Article: https://ow.ly/MQxL50SkmW1
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
